Genovate Biotechnology Co Ltd TPEX:4130:
PLANS TO SELL UP TO 80 MILLION SHARES VIA PRIVATE PLACEMENT
PRICING HAS YET TO BE DETERMINED
FUNDING FROM SHARE SALE WOULD BE USED TO MITIGATE TARIFFS IMPACT, STRENGTHEN GLOBAL PRESENCE
Genovate Biotechnology Co Ltd TPEX:4130:
PLANS TO SELL UP TO 80 MILLION SHARES VIA PRIVATE PLACEMENT
PRICING HAS YET TO BE DETERMINED
FUNDING FROM SHARE SALE WOULD BE USED TO MITIGATE TARIFFS IMPACT, STRENGTHEN GLOBAL PRESENCE